rgc68,you may be right,however,Gileads Solvaldi is pricey at $85,000 US.....this doesn't mean BIT225 would be more attractive IF (and thats a big if..) it makes it to market in combo with int/rib or anything else...
What it does mean is that there is still scope for competition.
J8 is happy to argue on the BLT thread that the market is still open to competition for BLT's platform HCV treatment...yet states here on the BIT thread that "the Horse is Bolting" and the race for HCV treatments has been run and won.
Unfortunately that has the smell of hypocrisy...and you can't cry victim here.
(By the way J8 I hope BLT is successful).
GiddyUp and others are entitled to a reply when they see inaccuracies.
GL Holders
rgc68,you may be right,however,Gileads Solvaldi is pricey at...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
